文献速递慢性肾脏病

磷酸盐与胆固醇的相互作用:慢性肾脏病心血管疾病的新视角?

Phosphate meeting cholesterol-consequences for cardiovascular disease in chronic kidney disease?
PubMed 文献 · Kidney Int · 2021-01-01

心血管疾病在慢性肾脏病患者中高度流行,高磷血症与亚临床动脉粥样硬化相关。Zhou等新近证明磷酸盐通过增加3-羟基-3-甲基戊二酰辅酶A还原酶激活,促进血管平滑肌和巨噬细胞中胆固醇的从头合成。这一观察可能改变慢性肾脏病中动脉粥样硬化发生和管理的现有概念。

要点

  • 磷酸盐促进血管平滑肌和巨噬细胞胆固醇从头合成
  • 机制涉及HMG-CoA还原酶激活
  • 可能改变CKD动脉粥样硬化管理概念

核心结论

  • 磷酸盐通过增加HMG-CoA还原酶激活促进血管平滑肌和巨噬细胞胆固醇从头合成,可能改变CKD中动脉粥样硬化的概念。

主要发现

  • 磷酸盐通过增加3-羟基-3-甲基戊二酰辅酶A还原酶激活,促进血管平滑肌和巨噬细胞中胆固醇从头合成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiovascular disease is highly prevalent in patients with chronic kidney disease. Hyperphosphatemia is associated with subclinical atheromatosis in chronic kidney disease. Phosphate-induced endothelial dysfunction and vascular calcification are thought to be key inducers of atherosclerosis in this condition. Zhou et al. now demonstrate that phosphate promotes de novo cholesterol synthesis in vascular smooth muscle and macrophages through increased 3-hydroxy-3-methylglutaryl coenzyme A reductase activation. This observation may change current concepts of atherosclerosis development and management in chronic kidney disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Hénaut L, Massy ZA. Phosphate meeting cholesterol-consequences for cardiovascular disease in chronic kidney disease? Kidney Int. 2021. PMID: 34023025. doi:10.1016/j.kint.2021.02.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。